(Q51608468)

8 April 2018

title

Vancomycin: we can't get there from here (English)

1 reference

8 April 2018

1 reference

1 reference

8 April 2018

author name string

Manjunath P Pai

1 reference

8 April 2018

Keith A Rodvold

1 reference

8 April 2018

Ben Lomaestro

1 reference

8 April 2018

George L Drusano

1 reference

8 April 2018

Thomas P Lodise

1 reference

8 April 2018

language of work or name

English

0 references

publication date

1 April 2011

1 reference

8 April 2018

Clinical Infectious Diseases

published in

1 reference

8 April 2018

volume

1 reference

8 April 2018

issue

1 reference

8 April 2018

page(s)

969-974

1 reference

8 April 2018

Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR078

Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR078

Basic pharmacodynamics of antibacterials with clinical applications to the use of beta-lactams, glycopeptides, and linezolid

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR078

The pharmacokinetic and pharmacodynamic properties of vancomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR078

Antimicrobial pharmacodynamics: critical interactions of 'bug and drug'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR078

Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR078

High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR078

Nephrotoxicity of continuous versus intermittent infusion of vancomycin in outpatient parenteral antimicrobial therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR078

Risk factors for nephrotoxicity associated with continuous vancomycin infusion in outpatient parenteral antibiotic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR078

Larger vancomycin doses (at least four grams per day) are associated with an increased incidence of nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR078

Vancomycin pharmacokinetics in patients with various degrees of renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR078

Levofloxacin compared with imipenem/cilastatin followed by ciprofloxacin in adult patients with nosocomial pneumonia: A multicenter, prospective, randomized, open-label study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR078

Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR078

Pharmacodynamics: relation to antimicrobial resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR078

Pharmacodynamics of vancomycin at simulated epithelial lining fluid concentrations against methicillin-resistant Staphylococcus aureus (MRSA): implications for dosing in MRSA pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR078

Activities of clindamycin, daptomycin, doxycycline, linezolid, trimethoprim-sulfamethoxazole, and vancomycin against community-associated methicillin-resistant Staphylococcus aureus with inducible clindamycin resistance in murine thigh [...]

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR078

Telavancin and vancomycin pharmacodynamics with Staphylococcus aureus in an in vitro dynamic model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR078

Vancomycin MICs for methicillin-resistant Staphylococcus aureus isolates differ based upon the susceptibility test method used

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR078

Correlation between free and total vancomycin serum concentrations in patients treated for Gram-positive infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR078

21 January 2018

Identifiers

DOI

10.1093/CID/CIR078

1 reference

8 April 2018

1 reference

8 April 2018